Atopic Dermatitis (Eczema)

Atopic dermatitis, also known as atopic eczema or eczema, is a chronic, itchy skin condition that is very common in children but may occur at any age. It is the most common form of dermatitis. It affects 15-20% of children but only 1-2% of adults.

Atopic dermatitis usually occurs in people who have an atopic tendency. This means they have inherited the tendency to allergic disorders and may develop any or all of three closely linked conditions; atopic dermatitis, asthma or allergic rhinitis (hayfever). Often these conditions run within families with a close relative also affected. A family history of these conditions is useful in diagnosing atopic dermatitis in infants.

It arises because of a combination of genetic and environmental factors. The primary problem is a defective skin barrier function making the skin more susceptible to damage from irritants such as soap, changes in the weather and temperature, and other non-specific triggers.

Atopic dermatitis patterns usually change with increasing age.

Infants less than one year old often have widely distributed rash. The skin is often dry, scaly and red. The cheeks of infants are often the first place to be affected by eczema.

The nappy area is frequently spared due to the moisture retention of nappies.

As a child grows, the atopic dermatitis becomes more localised and thickened. Toddlers scratch vigorously and the rash may look very raw and uncomfortable. Atopic dermatitis in this age group often affects the outer aspects of joints, particularly the wrists, elbows, ankles and knees.

Older children tend to have the flexural pattern of dermatitis where the creases of the joints are affected, especially the elbow and knee creases. The affected skin often becomes dry and thickened from constant scratching and rubbing. Other involved areas include the eyelids, earlobes, neck and scalp.

Atopic dermatitis is often worst between the ages of two and four but it generally improves during school years and it may completely clear up by the teens, although the barrier function of the skin is never normal.

Adults who have atopic dermatitis may present in various ways. They commonly have persistent localised dermatitis possibly confined to the hands, eyelids, flexures, nipples or all of these areas. Recurrent bacterial infections may be a problem. Hand dermatitis is more common in adults with atopic dermatitis.

Management

Management of atopic dermatitis may be required for many months and possibly years. There are a number of strategies to correct management:

  • Reduction of exposure to trigger factors (where possible).This may include an allergy assessment by an allergist to properly identify allergic triggers.
  • Short warm baths or showers, followed by application of topical steroid cream and moisturisers.
  • Regular moisturiser use should become a twice daily habit for affected individuals. Adequate amounts of appropriate moistures should be applied to maintain the skin barrier.
  • Intermittent topical steroids are an essential part of management and when used correctly under supervision are very safe in the long term. It is important to use adequate amounts of topical steroids.
  • All individuals with atopic dermatitis that is moderate to severe or persistent should have a plan devised with an allergy specialist or dermatologist.

There are more complicated, treatments (involving the immune system) available for the small number of people who have severe dermatitis not controlled by topical therapy. This must be prescribed and supervised by a specialist.

For more information on atopic dermatitis and eczema, including an Eczema Treatment Plan to be completed by your doctor visit http://www.allergy.org.au/patients/skin-allergy/eczema

Prepared by Professor CH Katelaris Oct 2012

A&AA© 2012

pdfAtopic Dermatitis (Eczema)216.44 KB

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.